Skip to main content
. Author manuscript; available in PMC: 2009 Aug 5.
Published in final edited form as: Oncogene. 2008 Dec 1;28(5):742–751. doi: 10.1038/onc.2008.430

Figure 3. Drug sensitivities in B-Myb overexpressing cell lines.

Figure 3

IC50 doses (72h) of chemotherapy on cell lines stably expressing vector control, B-Myb, or B-Myb S427G variant. Each MTT experiment was performed in triplicate and error bars represent 95% confidence intervals (*p<0.001 relative to vector control). (A) hTERT-immortalized HMEC line HME-CC. (B) hTERT-immortalized HMEC line ME16C. (C) Basal-like tumor derived cell line SUM102 and (D) SUM149.